These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38022742)

  • 21. Clinical features and outcomes of 35 disseminated intravascular coagulation cases treated with recombinant human soluble thrombomodulin at a single institution.
    Kawano N; Yoshida S; Ono N; Himeji D; Nagahiro Y; Sayaka Kawano ; Yamashita K; Ikeda N; Uezono S; Ochiai H; Kawano F; Kikuchi I; Ishikawa F; Shimoda K; Ueda A; Akashi K
    J Clin Exp Hematop; 2011; 51(2):101-7. PubMed ID: 22104308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Experience in the treatment with recombinant thrombomodulin on disseminated intravascular coagulation with severe urinary tract infection].
    Fumino M; Kurimoto K; Kinoshita N; Kato H; Arima K; Sugimura Y
    Hinyokika Kiyo; 2012 Feb; 58(2):71-4. PubMed ID: 22450831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical Efficacy of Recombinant Human Thrombomodulin for Surgical Patients with Disseminated Intravascular Coagulation Associated with Oncologic Emergency].
    Ikuta L; Nakajima T; Fujikawa M; Nomura K; Matsuki G; Ichise N; Kasai M; Okamoto R; Ikuta S; Nakamoto Y; Aihara T; Yanagi H; Yamanaka N
    Gan To Kagaku Ryoho; 2022 Dec; 49(13):1408-1410. PubMed ID: 36733084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment with recombinant thrombomodulin on disseminated intravascular coagulation caused by urinary tract infections; a retrospective comparative study with control cases].
    Machioka K; Shigehara K; Kadomoto S; Iwamoto H; Miyagi T; Nakashima T; Namiki M
    Hinyokika Kiyo; 2015 Jan; 61(1):1-6. PubMed ID: 25656012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of bleeding in patients with disseminated intravascular coagulation after receiving surgery and recombinant human soluble thrombomodulin: A cohort study using a database.
    Yamaguchi T; Kitajima Y; Miyauchi Y; Izawa K; Tanaka M; Hirata M; Sadatsuki Y; Ogawa Y
    PLoS One; 2018; 13(10):e0205146. PubMed ID: 30296304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinant human thrombomodulin for pneumonia-induced severe ARDS complicated by DIC in children: a preliminary study.
    Hirata N; Ngo DT; Phan PH; Ainai A; Phung TTB; Ta TA; Takasaki J; Kawachi S; Nunoi H; Nakajima N; Dien TM
    J Anesth; 2021 Oct; 35(5):638-645. PubMed ID: 34259911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical features and treatment outcomes of six patients with disseminated intravascular coagulation resulting from acute promyelocytic leukemia and treated with recombinant human soluble thrombomodulin at a single institution.
    Kawano N; Kuriyama T; Yoshida S; Yamashita K; Ochiai H; Nakazaki S; Tasaki A; Ueda A
    Intern Med; 2013; 52(1):55-62. PubMed ID: 23291674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Present and future of anticoagulant therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a perspective from Japan.
    Iba T; Thachil J
    Int J Hematol; 2016 Mar; 103(3):253-61. PubMed ID: 26588929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant human thrombomodulin in the treatment of acute myeloid leukemia patients complicated by disseminated intravascular coagulation: retrospective analysis of outcomes between patients treated with heparin and recombinant human thrombomodulin therapy.
    Takezako N; Sekiguchi N; Nagata A; Homma C; Takezako Y; Noto S; Natori K; Miwa A
    Thromb Res; 2015 Jul; 136(1):20-3. PubMed ID: 25934464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of Soluble Recombinant Human Thrombomodulin in Patients with Severe Acute Pancreatitis Complicated by Disseminated Intravascular Coagulation.
    Yano T; Taniguchi M; Shirasaka T; Tsuneyoshi I
    Turk J Anaesthesiol Reanim; 2019 Aug; 47(4):320-326. PubMed ID: 31380513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of Recombinant Human Soluble Thrombomodulin for Disseminated Intravascular Coagulation.
    Itoh S; Shirabe K; Kohnoe S; Sadanaga N; Kajiyama K; Yamagata M; Anai H; Harimoto N; Ikegami T; Yoshizumi T; Maehara Y
    Anticancer Res; 2016 May; 36(5):2493-6. PubMed ID: 27127163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of recombinant thrombomodulin for DIC after deceased donor liver transplantation: a case report.
    Kimura K; Yoshizumi T; Itoh S; Harimoto N; Motomura T; Harada N; Nagatsu A; Ikegami T; Ninomiya M; Soejima Y; Maehara Y
    Surg Case Rep; 2016 Dec; 2(1):81. PubMed ID: 27495993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment responses for disseminated intravascular coagulation in 25 children treated with recombinant thrombomodulin: a single institution experience.
    Yagasaki H; Kato M; Shimozawa K; Hirai M; Nishikawa E; Okuma H; Ishii W; Imai Y; Matsumura M; Yonezawa R; Yoshikawa K; Shichino H; Chin M; Mugishima H
    Thromb Res; 2012 Dec; 130(6):e289-93. PubMed ID: 23123162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors and treatments for disseminated intravascular coagulation in neonates.
    Go H; Ohto H; Nollet KE; Kashiwabara N; Ogasawara K; Chishiki M; Hiruta S; Sakuma I; Kawasaki Y; Hosoya M
    Ital J Pediatr; 2020 Apr; 46(1):54. PubMed ID: 32349778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of recombinant human soluble thrombomodulin in patients with sepsis-induced disseminated intravascular coagulation - A meta-analysis.
    Kato H; Hagihara M; Asai N; Umemura T; Hirai J; Mori N; Yamagishi Y; Iwamoto T; Mikamo H
    Thromb Res; 2023 Jun; 226():165-172. PubMed ID: 37182388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of combination therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation.
    Iba T; Hagiwara A; Saitoh D; Anan H; Ueki Y; Sato K; Gando S
    Ann Intensive Care; 2017 Nov; 7(1):110. PubMed ID: 29098447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sepsis-related coagulopathy treatment based on the disseminated intravascular coagulation diagnostic criteria: a post-hoc analysis of a prospective multicenter observational study.
    Wada T; Yamakawa K; Kabata D; Abe T; Fujishima S; Kushimoto S; Mayumi T; Ogura H; Saitoh D; Shiraishi A; Otomo Y; Gando S;
    J Intensive Care; 2023 Mar; 11(1):8. PubMed ID: 36872342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The efficacy and safety of antithrombin and recombinant human thrombomodulin combination therapy in patients with severe sepsis and disseminated intravascular coagulation.
    Yasuda N; Goto K; Ohchi Y; Abe T; Koga H; Kitano T
    J Crit Care; 2016 Dec; 36():29-34. PubMed ID: 27546744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sepsis-Associated DIC with Decreased Levels of Antithrombin and Fibrinogen is the Target for Combination Therapy with Thrombomodulin Alfa and Antithrombin.
    Wada H; Kawasugi K; Honda G; Kawano N; Uchiyama T; Madoiwa S; Takezako N; Suzuki K; Seki Y; Ikezoe T; Iba T; Okamoto K
    TH Open; 2023 Jan; 7(1):e65-e75. PubMed ID: 36846833
    [No Abstract]   [Full Text] [Related]  

  • 40. Can recombinant human thrombomodulin increase survival among patients with severe septic-induced disseminated intravascular coagulation: a single-centre, open-label, randomised controlled trial.
    Hagiwara A; Tanaka N; Uemura T; Matsuda W; Kimura A
    BMJ Open; 2016 Dec; 6(12):e012850. PubMed ID: 28039291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.